$169 Million is the total value of Vantage Consulting Group Inc's 212 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NOW | New | SERVICENOW INC | $338,183 | – | 871 | +100.0% | 0.20% | – |
| IBM | New | INTERNATIONAL BUSINESS MACHS | $328,415 | – | 2,331 | +100.0% | 0.19% | – |
| TRGP | New | TARGA RES CORP | $274,155 | – | 3,730 | +100.0% | 0.16% | – |
| CTLT | New | CATALENT INC | $246,925 | – | 5,486 | +100.0% | 0.15% | – |
| BKNG | New | BOOKING HOLDINGS INC | $217,650 | – | 108 | +100.0% | 0.13% | – |
| FRC | New | FIRST REP BK SAN FRANCISCO C | $216,111 | – | 1,773 | +100.0% | 0.13% | – |
| SIVB | New | SVB FINANCIAL GROUP | $216,792 | – | 942 | +100.0% | 0.13% | – |
| GOOG | New | ALPHABET INCcap stk cl c | $217,477 | – | 2,451 | +100.0% | 0.13% | – |
| GOOGL | New | ALPHABET INCcap stk cl a | $217,134 | – | 2,461 | +100.0% | 0.13% | – |
| ZION | New | ZIONS BANCORPORATION N A | $212,322 | – | 4,319 | +100.0% | 0.12% | – |
| CMA | New | COMERICA INC | $207,970 | – | 3,111 | +100.0% | 0.12% | – |
| MPWR | New | MONOLITHIC PWR SYS INC | $208,630 | – | 590 | +100.0% | 0.12% | – |
| CSCO | New | CISCO SYS INC | $201,660 | – | 4,233 | +100.0% | 0.12% | – |
| JNPR | New | JUNIPER NETWORKS INC | $201,923 | – | 6,318 | +100.0% | 0.12% | – |
| HSIC | New | HENRY SCHEIN INC | $202,231 | – | 2,532 | +100.0% | 0.12% | – |
| SBNY | New | SIGNATURE BK NEW YORK N Y | $200,483 | – | 1,740 | +100.0% | 0.12% | – |
| VIAC | New | PARAMOUNT GLOBAL | $183,958 | – | 10,898 | +100.0% | 0.11% | – |
| COTY | New | COTY INC | $103,704 | – | 12,115 | +100.0% | 0.06% | – |
| UIS | New | UNISYS CORP | $66,767 | – | 13,066 | +100.0% | 0.04% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $26,557 | – | 11,751 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROYALTY PHARMA PLC | 12 | Q3 2023 | 87.5% |
| ADC THERAPEUTICS SA SHS | 12 | Q3 2023 | 9.8% |
| FIBROGEN INC | 12 | Q3 2023 | 5.7% |
| COSTCO WHSL CORP NEW | 12 | Q3 2023 | 0.5% |
| WALMART INC | 12 | Q3 2023 | 0.5% |
| Sysco Corporation | 12 | Q3 2023 | 0.5% |
| Exxon Mobil Corporation | 12 | Q3 2023 | 0.5% |
| Chevron Corporation | 12 | Q3 2023 | 0.5% |
| KROGER CO | 12 | Q3 2023 | 0.5% |
| CVS Health Corporation | 12 | Q3 2023 | 0.5% |
View Vantage Consulting Group Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SYNTAX ETF TRUST | September 11, 2023 | 717,132 | 52.2% |
| SYNTAX ETF TRUST | November 08, 2022 | 156,133 | 56.8% |
| SYNTAX ETF TRUSTSold out | June 24, 2021 | 0 | 12.4% |
View Vantage Consulting Group Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G/A | 2023-09-11 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| SC 13G/A | 2022-11-08 |
| SC 13G/A | 2022-10-04 |
View Vantage Consulting Group Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.